Pfizer's 7% Dividend: Income Gem or Value Trap?

Pfizer (NYSE: PFE) has become the dividend investor's siren song. With shares down 31% over the past five years and a current yield of 7%, the pharmaceutical giant offers one of the juiciest payouts in the entire healthcare sector.For income-hungry investors watching bonds yield 4% to 5%, Pfizer's dividend may look irresistible. But before backing up the truck for that nearly 7% yield, you need to ask whether this is a value trap disguised as a high-powered income opportunity.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool